» Articles » PMID: 31315765

[Correlation Between Gut Microbiota and Behavior Symptoms in Children with Autism Spectrum Disorder]

Overview
Specialty Pediatrics
Date 2019 Jul 19
PMID 31315765
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the composition of gut microbiota and its correlation with the severity of behavior symptoms in children with autism spectrum disorder (ASD).

Methods: A total of 30 children with ASD were enrolled as the ASD group, and 20 healthy children matched for age and sex were enrolled as the healthy control group. Related clinical data were analyzed. The V3-V4 hypervariable regions of the bacterial 16S rRNA gene in fecal samples were sequenced. The severity of behavior symptoms in children with ASD was assessed using the autism behavior checklist. The Spearman's correlation analysis was used to investigate the correlation between gut microbiota and the severity of behavior symptoms in children with ASD.

Results: There was a significant difference in the composition of gut microbiota between the two groups. Compared with the healthy control group, the ASD group had significant reductions in Shannon index and Shannoneven index (P<0.05), as well as a significant reduction in the percentage of Firmicutes and a significant increase in the percentage of Acidobacteria in feces (P<0.05). In the ASD group, the dominant bacteria were Megamonas, Megasphaera, and Barnesiella, while in the healthy control group, the dominant bacteria were Eubacterium_rectale_group, Ezakiella, and Streptococcus. In the children with ASD, the abundance of Megamonas was positively correlated with the scores of health/physical/behavior and language communication (P<0.05).

Conclusions: The development of ASD and the severity of behavior symptoms are closely associated with the composition of gut microbiota.

Citing Articles

Evaluation of the clinical efficacy of CCFM6432 in alleviating depression.

Tian P, Yang H, Hang F, Wang G, Mao X, Jin X Microbiome Res Rep. 2025; 3(4):49.

PMID: 39741947 PMC: 11684983. DOI: 10.20517/mrr.2024.33.


Correction of Batch Effect in Gut Microbiota Profiling of ASD Cohorts from Different Geographical Origins.

Scanu M, Del Chierico F, Marsiglia R, Toto F, Guerrera S, Valeri G Biomedicines. 2024; 12(10).

PMID: 39457661 PMC: 11504477. DOI: 10.3390/biomedicines12102350.


Contributions of Artificial Intelligence to Analysis of Gut Microbiota in Autism Spectrum Disorder: A Systematic Review.

Climent-Perez P, Martinez-Gonzalez A, Andreo-Martinez P Children (Basel). 2024; 11(8).

PMID: 39201866 PMC: 11352523. DOI: 10.3390/children11080931.


The Effect of Probiotic Supplementation on the Gut-Brain Axis in Psychiatric Patients.

Sabit H, Kassab A, Alaa D, Mohamed S, Abdel-Ghany S, Mansy M Curr Issues Mol Biol. 2023; 45(5):4080-4099.

PMID: 37232729 PMC: 10217264. DOI: 10.3390/cimb45050260.


[Diversity and functional prediction of gut microbiota in children with autism spectrum disorder].

Liu Z, Wu D, Qu A, Wang L Zhongguo Dang Dai Er Ke Za Zhi. 2022; 24(12):1356-1364.

PMID: 36544419 PMC: 9785081. DOI: 10.7499/j.issn.1008-8830.2207130.


References
1.
Huang H, Liu J, Yu Y, Mo L, Ge R, Zhang H . Regulation of TWIK-related potassium channel-1 (Trek1) restitutes intestinal epithelial barrier function. Cell Mol Immunol. 2015; 13(1):110-8. PMC: 4711681. DOI: 10.1038/cmi.2014.137. View

2.
Slattery J, MacFabe D, Frye R . The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood. Clin Med Insights Pediatr. 2016; 10:91-107. PMC: 5063840. DOI: 10.4137/CMPed.S38338. View

3.
Fombonne E . Epidemiology of pervasive developmental disorders. Pediatr Res. 2009; 65(6):591-8. DOI: 10.1203/PDR.0b013e31819e7203. View

4.
Wang H, Wang P, Wang X, Wan Y, Liu Y . Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012; 57(12):3126-35. DOI: 10.1007/s10620-012-2259-4. View

5.
Lai M, Lombardo M, Baron-Cohen S . Autism. Lancet. 2013; 383(9920):896-910. DOI: 10.1016/S0140-6736(13)61539-1. View